Table 6.
Antibacterial and antifungal capacities of SlEOs and main individual compounds.
| SlEO/Compound | Escherichia coli | Staphylococcus aureus | Candida albicans | |||
|---|---|---|---|---|---|---|
| MIC (mg/mL) | MBC (mg/mL) | MIC (mg/mL) | MBC (mg/mL) | MIC (mg/mL) | MFC (mg/mL) | |
| SlEO-1 | 9.0 | 9.0 | 4.5 | 4.5 | 2.2 | 4.5 |
| SlEO-2 | 8.9 | 8.9 | 4.5 | 4.5 | 2.2 | 4.5 |
| SlEO-3 | 8.9 | 8.9 | 4.5 | 4.5 | 2.2 | 4.5 |
| SlEO-4 | 8.9 | 8.9 | 4.4 | 4.4 | 2.2 | 4.4 |
| α-Pinene | 0.5 | 1.0 | 2.1 | >2.1 | 0.5 | 0.5 |
| Camphene | >2.0 | >2.0 | >2.0 | >2.0 | >2.0 | >2.0 |
| Sabinene | >2.0 | >2.0 | >2.0 | >2.0 | >2.0 | >2.0 |
| β-Pinene | >2.0 | >2.0 | >2.0 | >2.0 | >2.0 | >2.0 |
| Myrcene | >2.1 | >2.1 | >2.1 | >2.1 | >2.1 | >2.1 |
| p-Cymene | 1.0 | 2.0 | >2.0 | >2.0 | 0.5 | 0.5 |
| Limonene | 2.0 | 2.0 | 0.3 | 0.3 | 1.0 | 1.0 |
| 1,8-Cineole | >2.3 | >2.3 | >2.3 | >2.3 | >2.3 | >2.3 |
| Linalool | 1.1 | 2.3 | 0.6 | 1.1 | 2.3 | 2.3 |
| Camphor | >2.3 | >2.3 | >2.3 | >2.3 | >2.3 | >2.3 |
| Borneol | 1.1 | 1.1 | 0.3 | 0.3 | 0.6 | 0.6 |
| Terpinen-4-ol | 2.3 | 2.3 | 1.1 | 2.3 | >2.3 | >2.3 |
| α-Terpineol | 2.4 | 2.4 | 0.6 | 1.1 | >2.4 | >2.4 |
| Linalyl acetate | >3.0 | >3.0 | 3.0 | >3.0 | >3.0 | >3.0 |
| Bornyl acetate | >2.9 | >2.9 | 2.9 | >2.9 | >2.9 | >2.9 |
| β-Caryophyllene | >3.1 | >3.1 | >3.1 | >3.1 | >3.1 | >3.1 |
| α-Humulene | >3.0 | >3.0 | 1.6 | 3.0 | >3.0 | >3.0 |
| Streptomycin sulfate | 1.0 × 10−3 | 1.0 × 10−3 | 1.0 × 10−3 | 1.0 × 10−3 | NT | NT |
| Fluconazole | NT | NT | NT | NT | 4.0 × 10−3 | 4.0 × 10−3 |
NT = Not tested.